Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
138.3 USD | -1.25% | +4.04% | +5.20% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.20% | 14.09B | |
-1.27% | 105B | |
+3.41% | 97.5B | |
+1.86% | 22.19B | |
-16.46% | 21.33B | |
-8.49% | 18.68B | |
-42.33% | 16.6B | |
-20.53% | 14.52B | |
+28.61% | 10.99B | |
-24.30% | 8.63B |
- Stock Market
- Equities
- NBIX Stock
- News Neurocrine Biosciences, Inc.
- Neurocrine Biosciences : Goldman Sachs Adjusts Price Target for Neurocrine Biosciences to $121 From $124, Maintains Neutral Rating